Rare Disease Report

Amyloidosis Studies at Takeda Oncology

SEPTEMBER 08, 2015
James Radke, PhD

In a recent interview with Rare Disease Report, Dixie Esseltine, MD, FRCPC, of Takeda Oncology explains the studies underway to test bortezomib (Velcade) and ixazomib in patients with amyloidosis.

Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.